Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04241835
Title A Study of Oral Tazemetostat in Subjects With Moderate and Severe Hepatic Impairment With Advanced Malignancies
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Epizyme, Inc.
Indications

Advanced Solid Tumor

hematologic cancer

Therapies

Tazemetostat

Age Groups: senior | adult
Covered Countries USA | FRA | BEL

Facility Status City State Zip Country Details
Robert H. Lurie Comprehensive Cancer Center of Northwestern University Terminated Chicago Illinois 60611 United States Details
Comprehensive Cancer Center of Nevada Terminated Las Vegas Nevada 89014 United States Details
Gabrail Cancer Center Active, not recruiting Canton Ohio 44718 United States Details
Mary Crowley Cancer Research Recruiting Dallas Texas 75230 United States Details
Oncology Consultants - Texas Medical Center Recruiting Houston Texas 77030 United States Details
Antwerp University Hospital Recruiting Edegem Antwerp 2650 Belgium Details
Cliniques Universitaires Saint-Luc Recruiting Brussels 1200 Belgium Details
Institut Bergonie Recruiting Bordeaux Cedex 33076 France Details
Centre Oscar Lambret Recruiting Lille 59020 France Details
Hopital de la Timone Active, not recruiting Marseille 13005 France Details
Biokinetica S.A Przychodnia Jozefow Active, not recruiting Józefów Mazowieckie 05410 Poland Details
MedPolonia Recruiting Poznań Wielkopolskie 60693 Poland Details
Summit Clinical Research, s.r.o Recruiting Bratislava 831 01 Slovakia Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field